Showing results (781-790 of 1,005) with videos related to

Sort By:
Pageof 101
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 31, 2016
CYP2R1 polymorphisms are important modulators of circulating 25-hydroxyvitamin D levels in elderly females with vitamin insufficiency, but not of the response to vitamin D supplementationA Arabi, N Khoueiry-Zgheib, Z Awada, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2006
A phase I dose-finding clinical pharmacokinetic study of an oral formulation of irinotecan (CPT-11) administered for 5 days every 3 weeks in patients with advanced solid tumoursH Dumez, A Awada, M Piccart, et al.
International Journal of Industrial Ergonomics|December 24, 2025
Heat Stress and Heat-Related Illnesses among Male and Female Refugee Agricultural Workers in LebanonRima R Habib, Lina M Fakih, Ghida Al Nakib, et al.
Lasers in Medical Science|January 6, 2018
Effects of high-frequency near-infrared diode laser irradiation on the proliferation and migration of mouse calvarial osteoblastsRyo Kunimatsu, Hidemi Gunji, Yuji Tsuka, et al.
The EMBO Journal|December 9, 2022
Mechanical forces impair antigen discrimination by reducing differences in T-cell receptor/peptide-MHC off-ratesJohannes Pettmann, Lama Awada, Bartosz Różycki, et al.
Cells|November 26, 2022
Regorafenib Induces Senescence and Epithelial-Mesenchymal Transition in Colorectal Cancer to Promote Drug ResistancePashalina Kehagias, Nadège Kindt, Mohammad Krayem, et al.
Scientific Reports|November 28, 2023
Assessment of mycotoxins in cornflakes marketed in LebanonHussein F Hassan, Farah Awada, Hani Dimassi, et al.
Breast Cancer Research and Treatment|October 8, 2016
Cabozantinib for metastatic breast carcinoma: results of a phase II placebo-controlled randomized discontinuation studySara M Tolaney, Hovav Nechushtan, Ilan-Gil Ron, et al.
Breast Cancer Research and Treatment|December 16, 2003
Keeping data continuous when analyzing the prognostic impact of a tumor marker: an example with cathepsin D in breast cancerN Bossard, F Descotes, A G Bremond, et al.
Pageof 101